The list of essential medicines of the WHO includes trastuzumab both for early-stage as well as for metastatic HER2-positive breast cancer.7 The world cancer nongovernmental community, represented at World Health Assembly by the Union for International Cancer Control board members, is playing a key role in decreasing inequity in health care services. The gene discussed is ERBB2; the disease is cancer.